CRS 2025 Annual Meeting and Exposition

We are thrilled to invite you to the CRS 2025 Annual Meeting & Exposition, taking place in the vibrant city of Philadelphia, PA, USA, from July 14-18, 2025. This year, under the exciting theme "Next-Generation Delivery Innovations," we will explore groundbreaking advancements and transformative ideas in controlled release science and technology.

Join us for an inspiring week of insightful presentations, engaging discussions, and unparalleled networking opportunities with leading experts and innovators from around the world. Don't miss your chance to be part of this pivotal event, shaping the future of delivery science.

For more information, please visit the Conference homepage.

Workshop organized by the Phospholipid Research Center

The Phospholipid Research Center will organize a half-day workshop on the important topic of "Diagnostics with Phospholipids - Quality standards and areas of application".

Organizer

Prof. Dr. Simon Matoori (University Montréal, Canada)
Priv.-Doz. Dr. habil. Simon Drescher (Phospholipid Research Center Heidelberg, Germany)

Summary

This workshop focuses on the versatile applications of phospholipids in diagnostic technologies, highlighting their unique properties and potential across various fields. Designed for academic researchers and pharmaceutical industry professionals, the workshop will explore innovative uses of phospholipids, such as liposomal systems for assessing antimicrobial activity of membrane-active compounds, reactive oxygen species (ROS)-sensing liposomal reaction compartments for molecular diagnostics in chronic wounds, and phospholipid-coated ultrasound contrast agents for theranostic applications. Additionally, the role of phospholipids in photodynamic therapy will be discussed.

While emphasizing application-driven approaches, the workshop will also address essential quality considerations and their implications for the development and deployment of phospholipid-based diagnostic tools. Participants will gain valuable insights into cutting-edge research and practical applications, fostering a deeper understanding of how phospholipids can transform diagnostics in both clinical and research settings.

The workshop will conclude with an engaging panel discussion, providing participants with the opportunity to interact with the speakers, exchange ideas, and explore open questions in this rapidly evolving field.

Learning Objectives

To provide an understanding of the role of phospholipids in diagnostic applications, highlighting their physicochemical properties and their influence on diagnostic performance in various contexts, such as molecular diagnostics, imaging, and theranostics.
To inform participants about innovative uses of phospholipids in diagnostics, including liposomal systems for antimicrobial activity assays, phospholipid-coated ultrasound contrast agents, and ROS-sensing liposomal hydrogels, while discussing their practical implementation and benefits.
To engage the audience in discussions on the integration of quality considerations and application-driven research, emphasizing the advancements and challenges in leveraging phospholipids for diagnostics and their implications for clinical and research settings.

First Session

Priv.-Doz. Dr. habil. Simon Drescher (PRC Heidelberg, Germany): The Phospholipid Research Center Heidelberg: An introduction and ongoing research projects
Dr. Michael Kahn (Lipoid, Inc., USA): Phospholipids for use in Parenteral Applications
Dr. Alexander Kreft (Lipoid GmbH, Germany): The quality of phospholipids
Dr. Christian Nehls (Research Center Borstel, Leibnitz Lung Center, Germany) The use of liposomes in the assessment of antimicrobial activity of membrane-active compounds

Second Session

Prof. Dr. Simon Matoori (University Montréal, Canada): Reactive oxygen species-sensing liposomal hydrogel for molecular diagnostics in chronic wounds
Prof. Dr. Klazina Kooiman (Erasmus MC University Medical Center Rotterdam, the Netherlands): Theranostic phospholipid-coated ultrasound contrast agents for vascular disease and biofilm infections
Dr. Samir Cherkaoui (Bracco Suisse S.A., Switzerland): Lipid-shelled microbubbles and nanodroplets for diagnostic and therapy applications
Dr. Mans Broekgaarden (University Grenoble, France): Photodynamics and phospolipids: Controlled drug release and tumor permeation with light